May 2021

Email is not displaying correctly? View it in your browser.  
 
 
May 28, 2021
 
 
 

Aflac Cancer and Blood Disorders Center launches the Aflac Diversity, Equity, and Inclusion (DEI) Committee

The Aflac DEI Committee, led by Dr. Tamara New, will focus on patient care equity; promotion, retention and recruitment; education and training; and research. The mission of the committee is to create an environment of equity and inclusion where all providers, staff, and visitors feel respected and supported. The overall goal is to provide optimal care, regardless of race, ethnicity, religion, physical ability, and gender identity. In the process, we hope to contribute to increasing equity globally.

Our committee is comprised of our providers and staff who will continue to fulfill our mission: Dr. Staci Arnold, Dr. Glaivy Batsuli, Dr. Sharon Castellino, Dr. Nick DeGroote, Lakeysha Edwards-Wilson, CSW, Dr. Beatrice Gee, Dr. Curtis Henry, Rae Hunter, Dr. Juhi Jain, Dr. Kathryn Leung, Heather Miller, RN, Dr. Jason Payne, Christine Powell, PNP, Dr. Naadira Upshaw, and Dr. William G. Woods.
 
 
 
     
 
 
Joanna Newton Nominated for ASPHO Leadership Role
Dr. Newton was nominated by Special Interests Group (SIG) leadership and elected to serve as Vice Chair of the ASPHO Quality Improvement and Patient Safety (QIPS). She will be responsible for helping to set annual objectives, plan programming throughout the year for membership, and organize the session at the annual conference.
Read more
 
  
Fertility Preservation Program Hits Milestone with 1,000 Evaluations
Dr. Lillian Meacham and her team successfully completed their 1,000th fertility evaluation at the beginning of April. The team sees patients before cancer treatment or bone marrow transplant (including non-oncology patients). They also complete fertility status assessments for adolescents and young adults following treatment. This successful team includes Dr. Meacham (Director), Megan Pruitt, NP, James Ludemann, RN, Sonia Hoey, RN, Drs. Krista Childress and Wolfgang Cerwinka. Drs. James Klosky and Brooke Cherven lead the research effort for the program.
Learn more
 
 
 
     
 
 
'The Atlanta Protocol' Expanding through MOTIVATE Study
Dr. Robert Sidonio’s MOTIVATE study stems from the success of Atlanta Protocol and this approach will determine the safety and effectiveness of treatments for patients with severe Hemophilia A, expanding internationally and across multiple sites. 'The Atlanta Protocol' was developed by Drs. Sidonio, Glaivy Batsuli, and Shannon Meeks.
Read more
 
  
Wilbur Lam Receives Georgia Bio Golden Helix Award
Georgia Bio presents Distinguished Deal of the Year Award to Children’s Healthcare of Atlanta, Emory University and Georgia Institute of Technology for receiving $18.2 million to continue their verification of COVID-19 diagnostic tests as part of the NIH Rapid Acceleration of Diagnostics (RADx) initiative.
Read more
 
 
 

Welcome New Faculty

Please join us in welcoming the newest additions to the Aflac Cancer and Blood Disorders Center: Dr. Megan Brown, Assistant Professor (Hemostasis/Thrombosis); Christine Ben-Oduro, Scottish Rite Practice Manager; Christy Redd, Egleston Practice Operations Supervisor; Robin Ross, Cross-campus Practice Operations Supervisor; Dr. Vivien Sheehan, Associate Professor (Sickle Cell); Tanya Sommers, NP (Apheresis Team); Dr. Aisha Walker, Assistant Professor (Sickle Cell); and Dr. Yankai Zhang, Assistant Professor (Sickle Cell). Pictured clockwise from top left.
 
 
 
     
 
 
2021 Rally Foundation Grant Award Winners
This year, three of our faculty were awarded Rally Grants for the 2021-2022 grant cycle totaling $185,000! Congratulations to Drs. Andy Hong, Katharine Brock, and Muxiang Zhou.
Read more
 
  
2021 Doctors’ Day
In recognition of Doctors' Day, the Emory School of Medicine Recognitions Committee sent out a call for nominations for doctors across the School of Medicine who go above and beyond. Congratulations to Drs. Ross Fasano, Soumitri Sil, Beth Thompson, Naadira Upshaw, and Kirsten Williams for their wealth of knowledge and providing outstanding patient care.
Read more
 
 
 
     
 
 
Annual ASPHO Conference
The 2021 American Society of Pediatric Hematology and Oncology conference (ASPHO) took place virtually on April 21-24. Thank you to all of our faculty, staff and fellows who participated in moderating, speaking, poster presentations, and more. Special recognition goes to Dr. Karen Effinger on co-chairing the meeting in her role of Vice Chair of the ASPHO Planning Committee, as well as Dr. Chris Porter who is also on the Planning Committee. Congratulations to Drs. Holly Edington and Diana Fridyland, recipients of 2021 ASPHO Early Career Awards.
Read more
 
  
AztraZeneca Announces Collaboration with Sanguina on New Smartphone Application Study
Research-based health platform company, Sanguina, co-founders Erika Tyburski and Dr. Wilbur Lam, announced a collaboration with AstraZeneca on a study to develop a custom version of AnemoCheck Mobile, a smartphone application that provides noninvasive and equipment-free hemoglobin (Hgb) levels for patients with anemia of chronic kidney disease (CKD).
Read more
 
 
 
     
 
 
Peach Bowl LegACy Fund: Apply Today
We are excited to announce that the next cycle for the Peach Bowl LegACy fund is open. Please submit your Letter of Intent by Friday, June 4 at 5 PM EST to peach.bowl@emory.edu.
Learn more
 
  
10th Annual Southeastern Pediatric Research Conference
Register today for the 10th Annual Southeastern Pediatric Research Conference. This virtual event will take place on June 11, 2021.
Register today!
 
 
 

 
 
 

*Aumann WK, Maxfield CM, Heath JL
“Asymptomatic Skeletal Cystic Angiomatosis May Be Managed Conservatively With Close Observation” – Journal of Pediatric Hematology/Oncology
 
 
 

Caruso C, *Lam WA
“Point-of-Care Diagnostic Assays and Novel Preclinical Technologies for Hemostasis and Thrombosis” – Seminars in Thrombosis and Hemostasis
 
 
 

*Cash T, Fox E, Liu X, Minard CG, Reid JM, Scheck AC, Weigel BJ, Wetmore C
“A phase 1 study of prexasertib (LY2606368), a CHK1/2 inhibitor, in pediatric patients with recurrent or refractory solid tumors, including CNS tumors: A report from the Children's Oncology Group Pediatric Early Phase Clinical Trials Network (ADVL1515)” – Pediatric Blood & Cancer
 
 
 

Chambliss C, Richardson T, Onyekaba J, Cespedes J, Nti A, Harp KO, Buchannan-Perry, I, Stiles JK, *Gee BE
“Elevated neuregulin-1β levels correlate with plasma biomarkers of cerebral injury and high stroke risk in children with sickle cell anemia” – Endocrine and Metabolic Science
 
 
 

Hasgur S, Desbourdes L, Relation T, Overholt KM, Stanek JR, Guess AJ, Yu M, Patel P, Roback L, Dominici M, Otsuru S, *Horwitz EM
“Splenic macrophage phagocytosis of intravenously infused mesenchymal stromal cells attenuates tumor localization” – Cytotherapy
 
 
 

*Janardan SK, Balsamo LM, Ross WL, Rotatori J, Auerback C, Kadan-Lottick NS
“The association of health status and cancer history of young adult survivors of childhood cancer with parental accompaniment to survivorship clinic visits” – Supportive Care in Cancer
 
 
 

*MacDonald TJ, Liu J, Yu B, Malhotra A, Munson J, Park JC, Wang K, Fei B, Bellamkonda R, Arbiser J
“Liposome-Imipramine Blue Inhibits Sonic Hedgehog Medulloblastoma In Vivo” – Cancers
 
 
 

*Marchak JG, Devine KA, Hudson MM, Jacobson LA, Michel G, Peterson SR, Schulte F, Wakefield CE, Sands SA
“Systematic Review of Educational Supports of Pediatric Cancer Survivors: Current Approaches and Future Directions” – Journal of Clinical Oncology
 
 
 

*Miller TP, Aplenc R
“Evolution of Hematology Clinical Trial Adverse Event Reporting to Improve Care Delivery” – Current Hematologic Malignancy Reports
 
 
 

Arce NA, Cao W, Brown AK, Legan ER, Wilson MS, Xu ER, Berndt MC, Emsley J, Zhang XF, *Li R
“Activation of von Willebrand factor via mechanical unfolding of its discontinuous autoinhibitory module” – Nature Communications
 
 
 

*Zerra PE, Patel SR, Jajosky RP, Arthur CM, McCoy JW, Allen JWL, *Chonat S, Fasano RM, Roback J, *Josephson CD, Hendrickson JE, Stowell SR
“Marginal Zone B Cells Mediate a CD4 T Cell Dependent Extrafollicular Antibody Response Following RBC Transfusion in Mice” – Blood
 
 
 

*Zimowski KL, Petrillo T, Ho MD, Wechsler J, Shields JE, Denning G, Jhita N, Rivera AA, Escobar MA, Kempton CL, Camire RM, *Doering CB
“F5-Atlanta: A novel mutation in F5 associated with enhanced East Texas splicing and FV-short production” – Journal of Thrombosis and Haemostasis
 
 
 
 
  
 
 

Emory Home | CHOA Newsroom | Join the Fight | Contact Us
Have a story for Aflac Report? Submit your suggestion via email.